Vimarsana
Biggest News Aggregation in the World

Page 4 - Share Tips News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Share Tips. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Share Tips Today - Breaking & Trending Today

Experts line up these top 10 stock ideas despite rangebound trade in Nifty 50 - Vimarsana News

Experts line up these top 10 stock ideas despite rangebound trade in Nifty 50

On the lower side, 22,350-22,300 is the immediate key support for Nifty and as long as this holds, the chances of consolidation with positive is seen.

Chartist Talks: Mehul Kothari advises going long on these 2 stocks for the coming week - Vimarsana News

Chartist Talks: Mehul Kothari advises going long on these 2 stocks for the coming week

Kothari, DVP, who has around 15 years of work experience in technical research, is bullish on Balrampur Chini Mills and DCM Shriram for the coming week.

Hot Stocks: Bet on Ashok Leyland, REC, Hindustan Petroleum Corporation for health double-digit returns in short term - Vimarsana News

Hot Stocks: Bet on Ashok Leyland, REC, Hindustan Petroleum Corporation for health double-digit returns in short term

It is advisable to consider buying opportunities at the current market price, targeting potential upside levels ranging from 22,783 to 23,170 on the Nifty.

Trade Spotlight | Your blueprint for Welspun Corp, Trent, Ashok Leyland counters today - Vimarsana News

Trade Spotlight | Your blueprint for Welspun Corp, Trent, Ashok Leyland counters today

Ashok Leyland recorded healthy gains for yet another session and formed strong bullish candlestick pattern on the daily charts with above-average volumes.

Chartist Talks: Nifty Pharma likely scaling towards 20,000 mark in May, no overbought conditions in BHEL, says Jatin Gedia - Vimarsana News

Chartist Talks: Nifty Pharma likely scaling towards 20,000 mark in May, no overbought conditions in BHEL, says Jatin Gedia

The consolidation in Nifty Pharma index is likely to breakout on the upside, says Jatin Gedia, who is a technical research analyst at Sharekhan by BNP Paribas.